Published in AIDS Weekly, August 28th, 2006
"Amphora, which already has FDA safety clearance for human use, is in the best position to be the first approved microbicide that will be available over-the-counter to protect women from HIV/AIDS," Thompson said. "By forming a company to focus exclusively on its testing and development, we think we can be to market first."
The market for a woman-controlled, over-the-counter microbicide/contraceptive is estimated to be $10...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.